Columbia’s Hadden Abuse Report Lands Years Late, Survivors Say Accountability Still Elusive

An overdue report into Columbia University’s handling of a notorious gynecologist’s sex crimes reveals more about institutional inertia than genuine accountability—a matter with profound implications for trust in New York’s elite institutions.

Marissa Hoechstetter’s voice—calm yet edged with frustration—echoes the mood of New York’s medical establishment this week. For more than a decade, survivors like her have agitated for reckoning after Robert Hadden, a gynecologist affiliated with Columbia University and NewYork-Presbyterian Hospital, was revealed as a prolific sexual predator. It took 14 years, 1,000 settlements, and a federal conviction before Hadden saw the inside of a prison cell. Now, Columbia’s long-awaited investigative report on its own failures promises reflection—yet survivors call it a masterclass in sidestepping blame.

Published just days before New York state’s Attorney General disclosed a parallel inquiry, the report was the product of a year-long review by Sidley Austin LLP, led by Joan Loughnane. Its remit: to probe how one of New York’s most venerated medical institutions—armed with prestige and resource—could have enabled abuse on this scale. The university, after all, paid out nearly $1 billion to victims, and the matter remains far from closed in the public imagination.

The review is thorough in a procedural sense, drawing from 120 interviews, including many survivors and dozens of staff. It paints a picture of a culture where status silenced complaints; decision-making was described as “ad hoc;” staff hesitated to question doctors, while leaders deferred to internal hierarchies. When patients or staff did raise alarms—Hadden’s first arrest in 2012 merited only an internal slap on the wrist—the response was to let him return to practice. Only later that year was he finally forced out.

Yet for those most harmed, the report’s conclusions are paltry. Critics quickly noted the review’s constricted scope: by focusing only on the years Hadden was employed, it sidesteps what they see as the real institutional sin—years of active legal maneuvering by Columbia to “bury, mislead and discredit” those seeking justice. Hoechstetter, who has become a figurehead for reform, calls the report “too little, too late.”

For Columbia, the first-order implications are plain. The university’s claim to trustworthiness—a key asset in the hypercompetitive landscape of New York’s health care sector—sits on shakier ground. Ongoing litigation, regulatory scrutiny, and now a fresh probe by the Attorney General threaten further reputational erosion. In a city beset by medical distrust, especially among women and minorities, this spells trouble.

Wider consequences spiral outwards. New York’s status as a global medical hub relies not simply on world-class surgeons and gleaming infrastructure, but on the conviction that institutions act with integrity. Events like these stoke scepticism, not just toward one university, but—potentially—toward medical and academic elites writ large. At a moment when American confidence in experts wobbles, the spectacle of a billion-dollar hush fund portends little comfort.

The political reverberations are equally pointed. Both Columbia and NewYork-Presbyterian have spent the past decade honing diversity and ethics initiatives—apparently to little effect, if such a predator could operate undisturbed. City Council members, alongside Manhattan’s powerful hospital-worker unions and patient safety advocates, smell blood in the water. The burgeoning scope of law enforcement involvement—now encompassing both federal and state agencies—could portend costlier settlements or even criminal exposures for executives.

Economically, the sums are sobering but not ruinous for these deep-pocketed institutions. Yet the real cost may accrue long-term: diminished patient intake, stricter regulatory oversight, and new requirements for transparency could squeeze margins in a sector already wrestling with post-pandemic staffing and insurance woes.

On a national scale, New York is hardly alone. The Hadden affair mirrors infamous scandals at other elite medical organizations, from Larry Nassar at Michigan State to patterns of abuse in church and collegiate settings. The tendency to prioritize institutional prestige—a quality New York should know is both asset and liability—over patient safety or transparency is regrettably common. In a phenomenon peculiarly American, the legal muscle of leading non-profits is routinely deployed to limit liability rather than expose bad actors. Columbia is thus only the latest poster child for a chronic ill.

Americans’ litigiousness may offer one inadequate accountability mechanism, but it is no substitute for genuine reform. Data from the federal Health Resources and Services Administration suggest that underreporting of abuse by medical professionals remains endemic. Studies consistently show strong “halo effects” in academic medicine, shielding doctors—even those with numerous complaints—from meaningful sanction.

Institutions lag public sentiment

There are glimmers of corrective momentum. The state’s Attorney General, keen to avoid the reputational crater facing cy Vance, Manhattan’s former District Attorney, has signaled a wider lens: not just the years of direct abuse, but the decade-plus of institutional response. Whispers of legislative overhaul—mandated reporting, external whistleblowing channels, automatic reviews of patient complaints—now circulate in Albany. A city famed for inertia may, under duress, be forced to modernize.

Still, it is far from clear that Columbia’s leaders have internalized the scale of their internal failure. The reliance on law firms to manage survivor relations—rather than, say, medical or ethical advisors—speaks to a defensive, not transformative, posture. To outside eyes, even this week’s contrition feels studied. The code of silence in elite medicine, hard-wired over decades, dies hard; incentives still reward reputation management above ground-level patient protection.

Throughout, what stands out is not simply Columbia’s unique failings, but the larger, ambient risk inherent in gilded institutional culture. When hierarchies grow rigid and trust in titles outpaces trust in people, systems falter. Transparency, not legalese, is the likelier solvent for such misdeeds.

The lesson for New York—and America—is unsparing. Prestige is no panacea. Management by subpoena or post-facto apology is no substitute for open governance and meaningful accountability. Columbia’s billion-dollar settlements and corporate apologies may clear the legal docket, but public confidence, once punctured, is not so easily restored. If the city’s leaders wish to command trust, they would do well to heed not only the letter of reform but its spirit. For now, survivors await evidence that their sacrifice mattered beyond the line-item of a balance sheet. ■